As of 2025-07-01, the Relative Valuation of Catalyst Pharmaceuticals Inc (CPRX) is 21.20 USD. This relative valuation is based on P/E multiples. With the latest stock price at 21.19 USD, the upside of Catalyst Pharmaceuticals Inc based on Relative Valuation is 0.1%.
The range of the Relative Valuation is 19.59 - 35.41 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 19.1x | 13.1x |
| Forward P/E multiples | 13.6x - 24.5x | 14.7x |
| Fair Price | 19.59 - 35.41 | 21.20 |
| Upside | -7.5% - 67.1% | 0.1% |
| Date | P/E |
| 2025-06-30 | 13.41 |
| 2025-06-27 | 13.46 |
| 2025-06-26 | 13.53 |
| 2025-06-25 | 13.31 |
| 2025-06-24 | 13.64 |
| 2025-06-23 | 13.67 |
| 2025-06-20 | 13.89 |
| 2025-06-18 | 14.10 |
| 2025-06-17 | 14.35 |
| 2025-06-16 | 14.63 |
| 2025-06-13 | 14.54 |
| 2025-06-12 | 15.01 |
| 2025-06-11 | 15.71 |
| 2025-06-10 | 16.26 |
| 2025-06-09 | 15.97 |
| 2025-06-06 | 15.99 |
| 2025-06-05 | 15.67 |
| 2025-06-04 | 15.63 |
| 2025-06-03 | 15.40 |
| 2025-06-02 | 15.39 |
| 2025-05-30 | 15.43 |
| 2025-05-29 | 15.19 |
| 2025-05-28 | 15.17 |
| 2025-05-27 | 15.35 |
| 2025-05-23 | 15.14 |
| 2025-05-22 | 14.90 |
| 2025-05-21 | 15.03 |
| 2025-05-20 | 15.25 |
| 2025-05-19 | 15.22 |
| 2025-05-16 | 15.06 |
| 2025-05-15 | 14.70 |
| 2025-05-14 | 14.46 |
| 2025-05-13 | 14.62 |
| 2025-05-12 | 14.73 |
| 2025-05-09 | 14.44 |
| 2025-05-08 | 14.07 |
| 2025-05-07 | 14.50 |
| 2025-05-06 | 14.25 |
| 2025-05-05 | 15.02 |
| 2025-05-02 | 15.35 |
| 2025-05-01 | 15.00 |
| 2025-04-30 | 15.01 |
| 2025-04-29 | 15.01 |
| 2025-04-28 | 14.61 |
| 2025-04-25 | 14.49 |
| 2025-04-24 | 14.33 |
| 2025-04-23 | 14.29 |
| 2025-04-22 | 13.97 |
| 2025-04-21 | 13.61 |
| 2025-04-17 | 13.92 |